Cresco Labs (CRLBF) Debt to Equity (2019 - 2026)

Cresco Labs has reported Debt to Equity for 8 years, with the latest figure at $1.73 in Q1 2026.

• For the quarter ending Q1 2026, Debt to Equity changed N/A year-over-year to $1.73; the trailing twelve-month figure through Mar 2026 stood at $1.73 (changed N/A YoY), and the FY2025 full-year result was $1.66, changed N/A from the prior year.
• Debt to Equity for Q1 2026 stood at $1.73, up from $1.66 in the prior quarter.
• The five-year high for Debt to Equity was $1.73 in Q1 2026, with the low at $0.0 in Q1 2022.
• Historically, Debt to Equity has averaged $1.1 across 5 years, with a median of $1.19 in 2024.
• Annual changes were most pronounced in 2023 — Debt to Equity jumped 78252.66% — and 2024, when it increased 19.29%.
• Cresco Labs' Debt to Equity stood at $0.83 in 2022, then surged by 43.38% to $1.19 in 2023, then grew by 15.43% to $1.37 in 2024, then climbed by 20.97% to $1.66 in 2025, then climbed by 4.31% to $1.73 in 2026.
• The last three Debt to Equity figures came in at $1.73 (Q1 2026), $1.66 (Q4 2025), and $1.37 (Q3 2024), per Business Quant data.